Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia

Journal of Leukocyte Biology

Volumn 83, Issue 3, 2008, Pages 589-601

  Wlodarski, Marcin W ^a,b   Nearman, Zachary ^a   Jankowska, Anna ^a   Babel, Nina ^b   Powers, Jennifer ^a   Leahy, Patrick ^c   Volk, Hans Dieter ^b   Maciejewski, Jaroslaw P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antigen driven; Autoimmune; CTL expansion; Viral infection

Indexed keywords

CD57 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR2; CXCL2 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON RELATED PROTEIN; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; INTEGRIN; INTERLEUKIN 18; MEYLOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TNF RECEPTOR SUPERFAMILY MEMBER 9 PROTEIN; TRANSCRIPTOME; DNA; TUMOR PROTEIN;

ADULT; AGED; ALLOGENEIC RESTRICTION; BONE MARROW DEPRESSION; CANCER PATIENT; CD8+ T LYMPHOCYTE; CELL SELECTION; CLINICAL ARTICLE; CLONAL VARIATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEVICE; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKEMIA CELL; LYMPHOCYTE CLONE; MALE; MICROARRAY ANALYSIS; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; VIRUS INFECTION; ARTICLE; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; MIDDLE AGED; PHENOTYPE;

HEPATITIS A VIRUS;

ADULT; AGED; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 43349093458     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0107073     Document Type: Conference Paper

References (79)

1. Martin, A., Barbesino, G., Davies, T. F. (1999) T-cell receptors and autoimmune thyroid disease - signposts for T-cell-antigen driven diseases. Int. Rev. Immunol. 18, 111-140.
2. Neumann, H., Medana, I. M., Bauer, J., Lassmann, H. (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25, 313-319.
3. Posnett, D. N., Gottlieb, A., Bussel, J. B., Friedman, S. M., Chiorazzi, N., Li, Y., Szabo, P., Farid, N. R., Robinson, M. A. (1988) T cell antigen receptors in autoimmunity. J. Immunol. 141, 1963-1969.
4. Ehl, S., Hombach, J., Aichele, P., Rulicke, T., Odermatt, B., Hengartner, H., Zinkernagel, R., Pircher, H. (1998) Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J. Exp. Med. 187, 763-774.
5. Maini, M. K., Gudgeon, N., Wedderburn, L. R., Rickinson, A. B., Beverley, P. C. (2000) Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J. Immunol. 165, 5729-5737.
6. Isa, A., Kasprowicz, V., Norbeck, O., Loughry, A., Jeffery, K., Broliden, K., Klenerman, P., Tolfvenstam, T., Bowness, P. (2005) Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med. 2, e343.
7. Aronsson, B., Troye-Blomberg, M., Smedman, L. (2004) Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination. J. Clin. Lab. Immunol. 53, 1-12.
8. Dummer, W., Niethammer, A. G., Baccala, R., Lawson, B. R., Wagner, N., Reisfeld, R. A., Theofilopoulos, A. N. (2002) T cell homeostatic proliferation elicits effective antitumor autoimmunity. J. Clin. Invest. 110, 185-192.
9. Handgretinger, R., Geiselhart, A., Moris, A., Grau, R., Teuffel, O., Bethge, W., Kanz, L., Fisch, P. (1999) Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N. Engl. J. Med. 340, 278-284.
10. Risitano, A. M., Kook, H., Zeng, W., Chen, G., Young, N. S., Maciejewski, J. P. (2002) Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V β CDR3 spectratyping and flow cytometry. Blood 100, 178-183.
11. Carlson, J. A., Grabowski, R., Chichester, P., Paunovich, E., Malfetano, J. (2000) Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous - implications for pathogenesis. Am. J. Dermatopathol. 22, 7-16.
12. Kook, H., Zeng, W., Guibin, C., Kirby, M., Young, N. S., Maciejewski, J. P. (2001) Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp. Hematol. 29, 1270-1277.
13. Sze, D. M., Giesajtis, G., Brown, R. D., Raitakari, M., Gibson, J., Ho, J., Baxter, A. G., Fazekas de St Groth, B., Basten, A., Joshua, D. E. (2001) Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood 98, 2817-2827.
14. Seder, R. A., Ahmed, R. (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4, 835-842.
15. Hamann, D., Baars, P. A., Rep, M. H., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., van Lier, R. A. (1997) Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186, 1407-1418.
16. Bigouret, V., Hoffmann, T., Arlettaz, L., Villard, J., Colonna, M., Ticheli, A., Gratwohl, A., Samii, K., Chapuis, B., Rufer, N., Roosnek, E. (2003) Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 101, 3198-3204.
17. Trimble, L. A., Kam, L. W., Friedman, R. S., Xu, Z., Lieberman, J. (2000) CD3ζ and CD28 down-modulation on CD8 T cells during viral infection. Blood 96, 1021-1029.
18. Sallusto, F., Lenig, D., Forster, R., Lipp, M., Lanzavecchia, A. (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401, 708-712.
19. Abo, T., Balch, C. M. (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 127, 1024-1029.
20. Kern, F., Ode-Hakim, S., Vogt, K., Hoflich, C., Reinke, P., Volk, H. D. (1996) The enigma of CD57+. Clin. Exp. Immunol. 104, 180-184.
21. Opferman, J. T., Korsmeyer, S. J. (2003) Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4, 410-415.
22. Mollet, L., Fautrel, B., Leblond, V., Bergeron, F., Merle-Beral, H., Baumelou, E., Hubert, P., Debre, P., Autran, B. (1999) Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT. Leukemia 13, 230-240.
23. Loughran Jr., T. P. (1993) Clonal diseases of large granular lymphocytes. Blood 82, 1-14.
24. Lamy, T., Loughran Jr., T. P. (1999) Current concepts: large granular lymphocyte leukemia. Blood Rev. 13, 230-240.
25. Loughran Jr., T. P., Starkebaum, G. (1987) Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 66, 397-405.
26. Lima, M., Almeida, J., Santos, A. H., dos Anjos Teixeira, M., Alguero, M. C., Queiros, M. L., Balanzategui, A., Justica, B., Gonzalez, M., San Miguel, J. F., Orfao, A. (2001) Immunophenotypic analysis of the TCR-Vβ repertoire in 98 persistent expansions of CD3(+)/TCR-αβ(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am. J. Pathol. 159, 1861-1868.
27. Loughran Jr., T. P., Starkebaum, G., Aprile, J. A. (1988) Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia. Blood 71, 822-824.
28. Melenhorst, J. J., Eniafe, R., Follmann, D., Molldrem, J., Kirby, M., El Ouriaghli, F., Barrett, A. J. (2003) T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol. J. 4, 18-25.
29. Sokol, L., Loughran Jr., T. P. (2006) Large granular lymphocyte leukemia. Oncologist 11, 263-273.
30. Lamy, T., Loughran Jr., T. P. (2003) Clinical features of large granular lymphocyte leukemia. Semin. Hematol. 40, 185-195.
31. Perzova, R., Loughran Jr., T. P. (1997) Constitutive expression of Fas ligand in large granular lymphocyte leukemia. Br. J. Haematol. 97, 123-126.
32. Kothapalli, R., Nyland, S. B., Kusmartseva, I., Bailey, R. D., McKeown, T. M., Loughran Jr., T. P. (2005) Constitutive production of proinflammatory cytokines RANTES, MIP-1β and IL-18 characterizes LGL leukemia. Int. J. Oncol. 26, 529-535.
33. Kothapalli, R., Bailey, R. D., Kusmartseva, I., Mane, S., Epling-Burnette, P. K., Loughran Jr., T. P. (2003) Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int. J. Oncol. 22, 33-39.
34. Coakley, G., Iqbal, M., Brooks, D., Panayi, G. S., Lanchbury, J. S. (2000) CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum. 43, 834-843.
35. Wlodarski, M. W., O'Keefe, C., Howe, E. C., Risitano, A. M., Rodriguez, A., Warshawsky, I., Loughran Jr., T. P., Maciejewski, J. P. (2005) Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 106, 2769-2780.
36. Schade, A. E., Powers, J. J., Wlodarski, M. W., Maciejewski, J. P. (2006) Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 107, 4834-4840.
37. Lamy, T., Liu, J. H., Landowski, T. H., Dalton, W. S., Loughran Jr., T. P. (1998) Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 92, 4771-4777.
38. Liu, J. H., Wei, S., Lamy, T., Li, Y., Epling-Burnette, P. K., Djeu, J. Y., Loughran Jr., T. P. (2002) Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood 100, 1449-1453.
39. Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J. M., Yang-Yen, H. F., Karras, J., Jove, R., Loughran Jr., T. P. (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 107, 351-362.
40. Epling-Burnette, P. K., Loughran Jr., T. P. (2003) Survival signals in leukemic large granular lymphocytes. Semin. Hematol. 40, 213-220.
41. Melenhorst, J. J., Brummendorf, T. H., Kirby, M., Lansdorp, P. M., Barrett, A. J. (2001) CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis. Leuk. Res. 25, 699-708.
42. Shvidel, L., Duksin, C., Tzimanis, A., Shtalrid, M., Klepfish, A., Sigler, E., Haran, M., Eilat, E., Berrebi, A. (2002) Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders. Hematol. J. 3, 32-37.
43. Kothapalli, R., Yoder, S. J., Mane, S., Loughran Jr., T. P. (2002) Microarray results: how accurate are they? BMC Bioinformatics 3, 22.
44. Semenzato, G., Zambello, R., Starkebaum, G., Oshimi, K., Loughran Jr., T. P. (1997) The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 89, 256-260.
45. Langerak, A. W., van den Beemd R., Wolvers-Tettero, I. L., Boor, P. P., van Lochem, E. G., Hooijkaas, H., van Dongen, J. J. (2001) Molecular and flow cytometric analysis of the Vβ repertoire for clonality assessment in mature TCRαβ T-cell proliferations. Blood 98, 165-173.
46. O'Keefe, C. L., Plasilova, M., Wlodarski, M., Risitano, A. M., Rodriguez, A. R., Howe, E., Young, N. S., Hsi, E., Maciejewski, J. P. (2004) Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J. Immunol. 172, 1960-1969.
47. Wlodarski, M. W., Gondek, L. P., Nearman, Z. P., Plasilova, M., Kalaycio, M., Maciejewski, J. P. (2006) Molecular strategies for detection and quantitation of clonal cytotoxic T cell responses in aplastic anemia and myelodysplastic syndrome. Blood 108, 2632-2641.
48. Zeng, W., Miyazato, A., Chen, G., Kajigaya, S., Young, N. S., Maciejewski, J. P. (2006) Interferon-γ-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood 107, 167-175.
49. Zeng, W., Kajigaya, S., Chen, G., Risitano, A. M., Nunez, O., Young, N. S. (2004) Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients. Exp. Hematol. 32, 806-814.
50. Cheng, J., Sun, S., Tracy, A., Hubbell, E., Morris, J., Valmeekam, V., Kimbrough, A., Cline, M. S., Liu, G., Shigeta, R., Kulp, D., Siani-Rose, M. A. (2004) NetAffx gene ontology mining tool: a visual approach for microarray data analysis. Bioinformatics 20, 1462-1463.
51. Lewis, M. J., Gautier, V. W., Wang, X. P., Kaplan, M. H., Hall, W. W. (2000) Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals. J. Immunol. 165, 4127-4132.
52. Cook, W. J., Kramer, M. F., Walker, R. M., Burwell, T. J., Holman, H. A., Coen, D. M., Knipe, D. M. (2004) Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection. Virol. J. 1, 5.
53. Melchjorsen, J., Sorensen, L. N., Paludan, S. R. (2003) Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J. Leukoc. Biol. 74, 331-343.
54. Zlotnik, A., Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.
55. Guidotti, L. G., Chisari, F. V. (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91.
56. Epling-Burnette, P. K., Bai, F., Wei, S., Chaurasia, P., Painter, J. S., Olashaw, N., Hamilton, A., Sebti, S., Djeu, J. Y., Loughran, T. P. (2004) ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 23, 9220-9229.
57. Cooray, S. (2004) The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85, 1065-1076.
58. Loughran Jr., T. P., Hadlock, K. G., Perzova, R., Gentile, T. C., Yang, Q., Foung, S. K., Poiesz, B. J. (1998) Epitope mapping of HTLV envelope seroreactivity in LGL leukemia. Br. J. Haematol. 101, 318-324.
59. Loughran Jr., T. P., Coyle, T., Sherman, M. P., Starkebaum, G., Ehrlich, G. D., Ruscetti, F. W., Poiesz, B. J. (1992) Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 80, 1116-1119.
60. Tagawa, S., Mizuki, M., Onoi, U., Nakamura, Y., Nozima, J., Yoshida, H., Kondo, K., Mukai, T., Yamanishi, K., Kitani, T. (1992) Transformation of large granular lymphocytic leukemia during the course of a reactivated human herpesvirus-6 infection. Leukemia 6, 465-469.
61. Swa, S., Wright, H., Thomson, J., Reid, H., Haig, D. (2001) Constitutive activation of Lck and Fyn tyrosine kinases in large granular lymphocytes infected with the -herpesvirus agents of malignant catarrhal fever. Immunology 102, 44-52.
62. Sokol, L., Agrawal, D., Loughran Jr., T. P. (2005) Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia. Leuk. Res. 29, 381-387.
63. Bangham, C. R., Osame, M. (2005) Cellular immune response to HTLV-1. Oncogene 24, 6035-6046.
64. Nansen, A., Marker, O., Bartholdy, C., Thomsen, A. R. (2000) CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection. Eur. J. Immunol. 30, 1797-1806.
65. Jiang, J. Q., Balasubramanian, S., Hawley-Foss, N. C., Badley, A. D., Rosenthal, K. L., Copeland, K. F. (2003) Production of CD8+ T cell nonlytic suppressive factors by CD28, CD38, and HLA-DR subpopulations. AIDS Res. Hum. Retroviruses 19, 497-502.
66. Benito, J. M., Lopez, M., Lozano, S., Martinez, P., Gonzalez-Lahoz, J., Soriano, V. (2004) CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res. Hum. Retroviruses 20, 227-233.
67. Mocroft, A., Bofill, M., Lipman, M., Medina, E., Borthwick, N., Timms, A., Batista, L., Winter, M., Sabin, C. A., Johnson, M., Lee, C. A., Phillips, A., Janossy, G. (1997) CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 14, 158-162.
68. Sandilands, G. P., MacPherson, S. A., Burnett, E. R., Russell, A. J., Downie, I., MacSween, R. N. (1997) Differential expression of CD32 isoforms following alloactivation of human T cells. Immunology 91, 204-211.
69. Coggeshall, K. M. (2002) Regulation of signal transduction by the Fc receptor family members and their involvement in autoimmunity. Curr. Dir. Autoimmun. 5, 1-29.
70. Ma, B. Y., Mikolajczak, S. A., Danesh, A., Hosiawa, K. A., Cameron, C. M., Takaori-Kondo, A., Uchiyama, T., Kelvin, D. J., Ochi, A. (2005) The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. Blood 106, 2002-2010.
71. Cooper, D., Bansal-Pakala, P., Croft, M. (2002) 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol. 32, 521-529.
72. Saoulli, K., Lee, S. Y., Cannons, J. L., Yeh, W. C., Santana, A., Goldstein, M. D., Bangia, N., DeBenedette, M. A., Mak, T. W., Choi, Y., Watts, T. H. (1998) CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187, 1849-1862.
73. Cannons, J. L., Chamberlain, G., Howson, J., Smink, L. J., Todd, J. A., Peterson, L. B., Wicker, L. S., Watts, T. H. (2005) Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes. J. Autoimmun. 25, 13-20.
74. Ilan, N., Madri, J. A. (2003) PECAM-1: old friend, new partners. Curr. Opin. Cell Biol. 15, 515-524.
75. Prager, E., Staffler, G., Majdic, O., Saemann, M., Godar, S., Zlabinger, G., Stockinger, H. (2001) Induction of hyporesponsiveness and impaired T lymphocyte activation by the CD31 receptor:ligand pathway in T cells. J. Immunol. 166, 2364-2371.
76. Reedquist, K. A., Ross, E., Koop, E. A., Wolthuis, R. M., Zwartkruis, F. J., van Kooyk Y., Salmon, M., Buckley, C. D., Bos, J. L. (2000) The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J. Cell Biol. 148, 1151-1158.
77. Zehnder, J. L., Shatsky, M., Leung, L. L., Butcher, E. C., McGregor, J. L., Levitt, L. J. (1995) Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. Blood 85, 1282-1288.
78. Michels, J., O'Neill, J. W., Dallman, C. L., Mouzakiti, A., Habens, F., Brimmell, M., Zhang, K. Y., Craig, R. W., Marcusson, E. G., Johnson, P. W., Packham, G. (2004) Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 23, 4818-4827.
79. Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., Korsmeyer, S. J. (2003) Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426, 671-676.